Situations where CJC-1295 would generally be considered inappropriate or high-risk include: Active or prior cancer , given the theoretical role of elevated IGF-1 in tumor growth Diabetes or impaired glucose tolerance , because GH can worsen insulin resistance and raise blood sugar Pregnancy and breastfeeding , where there are no safety data whatsoever Children and adolescents , in whom manipulating the GH axis outside strict medical indications is inappropriate Serious cardiovascular, kidney, or liver disease , which fluid retention and metabolic shifts could aggravate Interactions to consider
For example, the inhibition of pentraxin-3 (Ptx3) can alleviate SLI through mechanisms involving the suppression of hepatocyte ferroptosis, a reduction in CCL20/CCR6 axis-mediated M1 macrophage recruitment, and the blockade of the NF-B pathway-induced polarization of M0 macrophages to the M1 phenotype (Wang H
Together, these effects create what some clinicians describe as metabolic youth, meaning the body performs more like it did years earlier
Additional Information: Net weight: Varies depending on packaging (e.g 500 mg per tablet or portion)
Stories Amid the Gravestones: Oakwood Cemetery (Sunday, September 20, 2026) - Sold Out 4 p.m
